Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Olazarán

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Neurologia (Barcelona, Spain)|October 25, 2002
[Galantamine: a novel cholinergic agent for Alzheimer's disease]J Olazarán, G García
Neurologia (Barcelona, Spain)|February 21, 1998
[Reflex sympathetic dystrophy due to phenobarbital: a frequent and treatable condition]J Olazarán, I Farcha
Revista De Neurologia|April 25, 2000
[Neurological evaluation of behavior]F J Olazarán-Rodríguez
Revista De Neurologia|June 24, 2005
[Changing the anticholinesterase in Alzheimer's disease]J Olazarán-Rodríguez, E Navarro-Merino
Neurologia (Barcelona, Spain)|October 12, 2005
[Clinical validity of two scales of instrumental activities in Alzheimer's disease]J Olazarán, P Mouronte, F Bermejo
Neurologia (Barcelona, Spain)|May 20, 2014
There is no scientific basis for retiring the MMSEJ Olazarán Rodríguez, F Bermejo Pareja
International Journal of Alzheimer'S Disease|October 26, 2013
Cumulative effect of depression on dementia riskJ Olazarán, R Trincado, F Bermejo-Pareja
Journal of Neurology|August 4, 2010
Cortical excitability in very mild Alzheimer's disease: a long-term follow-up studyJ Olazarán, J Prieto, I Cruz, et al.
Neurologia (Barcelona, Spain)|September 10, 2011
[Health care in dementia: satisfaction and needs of the caregiver]J Olazarán Rodríguez, M Sastre Paz, S Martín Sánchez
Neurologia (Barcelona, Spain)|February 9, 2002
[Usefulness of functional magnetic resonance imaging and spectroscopy in the diagnosis of frontotemporal dementia]F J Olazarán, J Alvarez-Linera, J Benito-León
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Neurologia (Barcelona, Spain)|October 25, 2002
[Galantamine: a novel cholinergic agent for Alzheimer's disease]J Olazarán, G García
Neurologia (Barcelona, Spain)|February 21, 1998
[Reflex sympathetic dystrophy due to phenobarbital: a frequent and treatable condition]J Olazarán, I Farcha
Revista De Neurologia|April 25, 2000
[Neurological evaluation of behavior]F J Olazarán-Rodríguez
Revista De Neurologia|June 24, 2005
[Changing the anticholinesterase in Alzheimer's disease]J Olazarán-Rodríguez, E Navarro-Merino
Neurologia (Barcelona, Spain)|October 12, 2005
[Clinical validity of two scales of instrumental activities in Alzheimer's disease]J Olazarán, P Mouronte, F Bermejo
Neurologia (Barcelona, Spain)|May 20, 2014
There is no scientific basis for retiring the MMSEJ Olazarán Rodríguez, F Bermejo Pareja
International Journal of Alzheimer'S Disease|October 26, 2013
Cumulative effect of depression on dementia riskJ Olazarán, R Trincado, F Bermejo-Pareja
Journal of Neurology|August 4, 2010
Cortical excitability in very mild Alzheimer's disease: a long-term follow-up studyJ Olazarán, J Prieto, I Cruz, et al.
Neurologia (Barcelona, Spain)|September 10, 2011
[Health care in dementia: satisfaction and needs of the caregiver]J Olazarán Rodríguez, M Sastre Paz, S Martín Sánchez
Neurologia (Barcelona, Spain)|February 9, 2002
[Usefulness of functional magnetic resonance imaging and spectroscopy in the diagnosis of frontotemporal dementia]F J Olazarán, J Alvarez-Linera, J Benito-León
Pageof 3